Two male gays talking about entertainment. Cover art photo provided by bharath g s Support this podcast: https://podcasters.spotify.com/pod/show/male-gaze/support
…
continue reading
Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.
…
continue reading
The Civil War was the most important event in American history. That's because it decided what kind of nation America would be and whether or not the promise of universal liberty would be fulfilled. And what decided the outcome of the Civil War was its battles. Hosted by history professors James Early and Scott Rank, this podcast explores the ten most important battles in the Civil War. It features every major conflict, from the initial shots fired at the Battle of First Bull Run to the end ...
…
continue reading
Everyone has a story, they are all different, and they are all important. We can learn so much from the experiences of others. Join the Ryan Furr Creative team as we hear stories from creatives, business owners, friends, and influencers.
…
continue reading
The PDX Executive Podcast features inspiring leaders from Portland and beyond.
…
continue reading
1
TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.
35:30
35:30
Play later
Play later
Lists
Like
Liked
35:30
We love to hear from our listeners. Send us a message. KSQ Therapeutics' CSO, Micah Benson, Ph.D., joins Erin Harris to discuss how Tumor-Infiltrating Lymphocytes (TILs) as a treatment modality have the potential to treat a variety of solid tumor types. Benson explains KSQ's Phase 1/2 clinical study, KSQ-001EX, which consists of TILs in which the S…
…
continue reading
1
Synthetic Biology and Programmable mRNA with Strand Therapeutics' Jake Becraft
27:52
27:52
Play later
Play later
Lists
Like
Liked
27:52
We love to hear from our listeners. Send us a message. Strand Therapeutics' CEO and Co-Founder Jake Becraft joins Erin Harris to discuss genetic regulation and how the company's programmable mRNA constructs combine genes for self-replication derived from RNA viruses with genetically programmed logic circuits that control the location, timing, and i…
…
continue reading
1
Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko
14:52
14:52
Play later
Play later
Lists
Like
Liked
14:52
We love to hear from our listeners. Send us a message. Elixirgen Therapeutics' Aki Ko joins Erin Harris to detail the company's Bobcat mRNA therapeutic and how it differs from traditional exon-skipping drugs and AAV-microdystrophin in treating DMD. Regarding delivery, Ko explains the advantage of the mRNA approach over the AAV approach.…
…
continue reading
1
The Current State of the Global Regulatory Landscape with ISCT's Dr. Bambi Grilley
25:21
25:21
Play later
Play later
Lists
Like
Liked
25:21
We love to hear from our listeners. Send us a message. Dr. Bambi Grilley is Professor of Pediatrics and the Director of Clinical Research and Early Product Development for the Center of Cell and Gene Therapy (CAGT) at Baylor College of Medicine AND she is Chief Regulatory Officer at ISCT. Dr. Grilley talks to us about her role as CRO at ISCT and th…
…
continue reading
1
Dr. Bruce Levine on ISCT and the Future of CAR-T
31:49
31:49
Play later
Play later
Lists
Like
Liked
31:49
We love to hear from our listeners. Send us a message. In anticipation of ISCT 2024 in Vancouver, Canada, Dr. Bruce Levine is back on Cell & Gene: The Podcast to share information about the event as well as his expertise on the future of CAR-T therapy for solid tumors, autoimmune disease, and more. He talks about his time and learnings as President…
…
continue reading
1
CGTs for HIV Suppression with Addimmune's Dr. Marcus Conant
18:51
18:51
Play later
Play later
Lists
Like
Liked
18:51
We love to hear from our listeners. Send us a message. Dr. Marcus Conant is CMO at Addimmune, a biotech startup developing a cell therapy for HIV that spun out of cell and gene therapy biotech American Gene Technologies (AGT). He spent his career on the front lines of HIV treatment and research and remains an advocate for the HIV patient. He formed…
…
continue reading
1
Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah
29:39
29:39
Play later
Play later
Lists
Like
Liked
29:39
We love to hear from our listeners. Send us a message. BlueRock Therapeutics' SVP Head of Development, Dr. Ahmed Enayetallah, joins Cell & Gene: The Podcast Host, Erin Harris, to discuss the company's phase I clinical trial for Parkinson’s disease, which continues to show positive trends at 18 months. They cover the important role induced pluripote…
…
continue reading
1
Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang
23:08
23:08
Play later
Play later
Lists
Like
Liked
23:08
We love to hear from our listeners. Send us a message. In 2021 on Episode 13, Vor Bio’s President and CEO, Dr. Robert Ang shared data about the company’s lead engineered hematopoietic cell (eHSC) product candidate. Dr. Ang is back to talk to Cell & Gene: The Podcast Host, Erin Harris, about how Vor has treated 8 patients demonstrating clinical proo…
…
continue reading
1
Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan
19:37
19:37
Play later
Play later
Lists
Like
Liked
19:37
We love to hear from our listeners. Send us a message. Orca Bio's CMO, Dr. Scott McClellan, joins Erin Harris on this episode of Cell & Gene: The Podcast to discuss how and why toxicities continue to stymie allogeneic cell therapies. They cover Orca Bio's plan to potentially lowering the risk of GvHD as well as Orca-T, the investigational high-prec…
…
continue reading
1
Ivan McClellan: Author of Black Rodeo Culture & Founder, 8 Seconds Juneteenth Rodeo
23:17
23:17
Play later
Play later
Lists
Like
Liked
23:17
Ivan McClellan is the Founder and CEO of Eight Seconds and the Eight Seconds Rodeo. Driven by a sense of purpose, his work has transformed the lives of these cowboys and influenced the western space. He has executed numerous campaigns for Wrangler, Tecovas, Boot Barn, Stetson, Ariat and many other brands highlighting the spectacular Black cowboys d…
…
continue reading
1
Inside Cellular Rejuvenation Therapies for Age-Related Diseases with Life Biosciences' Sharon Rosenzweig-Lipson, Ph.D.
17:17
17:17
Play later
Play later
Lists
Like
Liked
17:17
We love to hear from our listeners. Send us a message. On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Life Biosciences' CSO, Sharon Rosenzweig-Lipson, Ph.D., about the Boston-based biotech's cellular rejuvenation therapies for the treatment of age-related diseases. They cover Life Biosciences' lead program, a gene therapy ca…
…
continue reading
1
K.L. Wombacher, President and General Manager of the Hillsboro Hops
37:55
37:55
Play later
Play later
Lists
Like
Liked
37:55
K.L. Wombacher is the President and General Manager of the Hillsboro Hops, the minor league baseball team affiliated with the Arizona Diamondbacks.By Dan Bruton
…
continue reading
1
The Future of Rare Diseases with The Jackson Laboratory’s Rare Disease Translational Center's Cat Lutz
27:31
27:31
Play later
Play later
Lists
Like
Liked
27:31
We love to hear from our listeners. Send us a message. Rare Disease Day is February 29, 2024, and in honor of this important day, Cell & Gene: The Podcast Host Erin Harris sits down with Jackson Laboratory’s (JAX) Rare Disease Translational Center (RDTC)'s VP, Cat Lutz. They discuss RDTC's mission, the specific qualifications that make up a rare di…
…
continue reading
1
Rob Bach on the Resurgence of Vinyl, CDs and Cassettes
21:08
21:08
Play later
Play later
Lists
Like
Liked
21:08
Rob Bach is the Founder of Spinney Media, an affordable, subscription-based physical fulfillment service for all working and aspiring musicians. Learn more at: https://spinneymedia.com/By Dan Bruton
…
continue reading
1
Inside Yescarta's Reduced Median Turnaround Time with Kite, a Gilead company's Christopher McDonald
20:48
20:48
Play later
Play later
Lists
Like
Liked
20:48
We love to hear from our listeners. Send us a message. On this episode of Cell & Gene: The Podcast, Christopher McDonald, Global Head of Technical Operations at Kite, a Gilead company, talks to Host Erin Harris about Kite's recent FDA approval of manufacturing process change resulting in reduced median turnaround time for Yescarta. They talk throug…
…
continue reading
1
Pricing, Value, And Access of CGTs With The Dedham Group's Jennifer Klarer, M.Sc.Eng.
37:17
37:17
Play later
Play later
Lists
Like
Liked
37:17
We love to hear from our listeners. Send us a message. The Dedham Group's Jennifer Klarer, M.Sc.Eng., Partner and Head of Cell & Gene Therapy, joins Erin Harris on this episode of Cell & Gene: The Podcast for a deep dive into pricing and value for CGTs. Klarer shares a detailed breakdown of the most misunderstood aspects of cell and gene therapy pr…
…
continue reading
1
Breaking Down Solid Tumors with Triumvira Immunologics' Dr. Paul Lammers
21:33
21:33
Play later
Play later
Lists
Like
Liked
21:33
We love to hear from our listeners. Send us a message. Paul Lammers, M.D., M.Sc., CEO of Triumvira Immunologics joins Cell & Gene: The Podcast to talk to Host Erin Harris about TAC, the company's proprietary T cell Antigen Coupler, which has both autologous and allogeneic approaches. They also discuss targeting relapsed or refractory HER2-positive …
…
continue reading
1
Amina Moreau, Co-Founder & CEO of Radious, on Flexible Work, Growth, and Rad Days
27:39
27:39
Play later
Play later
Lists
Like
Liked
27:39
Amina Moreau is the Co-Founder and CEO of Radious.pro, a marketplace for on demand private workspaces.By Dan Bruton
…
continue reading
1
4 Keys to Allo in 2024 with Poseida Therapeutics' Kristin Yarema, Ph.D.
31:59
31:59
Play later
Play later
Lists
Like
Liked
31:59
We love to hear from our listeners. Send us a message. Kristin Yarema, Ph.D., CEO, Poseida Therapeutics sits down with Cell & Gene: The Podcast Host Erin Harris to discuss four of the biggest challenges the CGT sector faces when it comes to the development of off-the-shelf therapies. Kristin shares how 2024 might see some real progress in allogenei…
…
continue reading
1
Cell Therapy For Corneal Endothelial Dystrophies With Aurion Biotech's Greg Kunst
13:41
13:41
Play later
Play later
Lists
Like
Liked
13:41
We love to hear from our listeners. Send us a message. For this third and final episode recorded at ARM's 2023 Meeting on the Mesa, Cell & Gene: The Podcast Host, Erin Harris, sat down with Greg Kunst, president, CEO, and Board member at Aurion Biotech. Listen in as they discuss the cell therapy used to treat corneal endothelial disease and how Gre…
…
continue reading
1
Oregon Treasurer Tobias Read on his Candidacy for Secretary of State
27:14
27:14
Play later
Play later
Lists
Like
Liked
27:14
Oregon Treasurer Tobias Ready rejoins the podcast and discusses his candidacy to become Oregon's next Secretary of State. Learn more at https://www.tobiasread.com/By Dan Bruton
…
continue reading
1
Overcoming the Limitations of CAR T-Cell Therapy with Vittoria Bio's Nick Siciliano, Ph.D.
17:23
17:23
Play later
Play later
Lists
Like
Liked
17:23
We love to hear from our listeners. Send us a message. Vittoria Biotherapeutics’ CEO, Nick Siciliano, joins Erin Harris on this episode of Cell & Gene: The Podcast to discuss the company's mission to expand the applications for CAR-based therapeutics by employing novel cell engineering and gene editing technologies.…
…
continue reading
1
Gene Therapy Deals, Collaborations, & Partnerships with Astellas' Richard Wilson
25:02
25:02
Play later
Play later
Lists
Like
Liked
25:02
We love to hear from our listeners. Send us a message. Richard Wilson, Senior Vice President, Primary Focus Lead, Genetic Regulation at Astellas sat down with Cell & Gene: The Podcast's Erin Harris at ARM's 2023 Meeting on the Mesa to discuss the gene therapy deal making landscape as well as Astellas' recent deals and collaborations. They also disc…
…
continue reading
1
The Promise of AAV Gene Therapy with REGENXBIO's Ken Mills
28:34
28:34
Play later
Play later
Lists
Like
Liked
28:34
We love to hear from our listeners. Send us a message. Ken Mills, CEO, President, and Director at REGENXBIO joins Erin Harris for this episode of Cell & Gene: The Podcast to discuss the company's progress with its Phase I/II Affinity Duchenne trial of RGX-202 for the treatment of Duchenne Muscular Dystrophy. They discuss the future of AAV gene ther…
…
continue reading
1
Inside 2023 Meeting on the Mesa with ARM's COO, Rita Johnson-Greene
16:33
16:33
Play later
Play later
Lists
Like
Liked
16:33
We love to hear from our listeners. Send us a message. Alliance for Regenerative Medicine's COO, Rita Johnson-Greene, joined Cell & Gene: The Podcast host, Erin Harris, in person at the 2023 Meeting on the Mesa to discuss this year's event. Johnson-Greene also shared what's ahead for 2024 as the event heads to a new location. They discussed major t…
…
continue reading
1
Mike Rogoway, Business Reporter for The Oregonian
30:51
30:51
Play later
Play later
Lists
Like
Liked
30:51
Mike Rogoway, Business Reporter for the Oregonian rejoins the show for his fifth guest appearance. Mike discusses the Oregon economy, startups, Intel/Chips industry, and more. Read Mike's columns at: https://www.oregonlive.com/user/MikeRogoway/posts.htmlFollow him on Twitter/X: @rogowayBy Dan Bruton
…
continue reading
1
The Future of Cell and Organ Transplantation in Treating T1D with Dr. Camillo Ricordi
18:15
18:15
Play later
Play later
Lists
Like
Liked
18:15
We love to hear from our listeners. Send us a message. A pioneer and an icon in diabetes research, Camillo Ricordi, M.D., is the Professor of Surgery, Director of Cell Transplant Center and Director Emeritus of the Diabetes Research Institute at the University of Miami Miller School of Medicine, Florida (UM-DRI). He joins Cell & Gene: The Podcast's…
…
continue reading
1
In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg
30:37
30:37
Play later
Play later
Lists
Like
Liked
30:37
We love to hear from our listeners. Send us a message. Umoja Biopharma's CEO, Andy Scharenberg, M.D., joins Cell & Gene: The Podcast's Erin Harris to discuss the evolution of allogeneic, in vivo CAR-T cell therapeutics. They discuss The Climb, or The Colorado Laboratory and Innovation Manufacturing Building, which is Umoja’s lentiviral vector devel…
…
continue reading
1
Inside Genome Editing with CBER's Dr. Peter Marks
25:17
25:17
Play later
Play later
Lists
Like
Liked
25:17
We love to hear from our listeners. Send us a message. The FDA's Center for Biologics Evaluation and Research (CBER)'s Dr. Peter Marks makes his second appearance on Cell & Gene: The Podcast. This time Dr. Marks talks to Host, Erin Harris, about base editing and prime editing and their potential to meet unmet medical need. They discuss what clinica…
…
continue reading
1
The Future of CAR-T with Bristol Myers Squibb's Lynelle Hoch
25:53
25:53
Play later
Play later
Lists
Like
Liked
25:53
We love to hear from our listeners. Send us a message. As SVP Cell Therapy Franchise Lead at Bristol Myers Squibb, Lynelle Hoch leads her team to bring more curative cell-based therapies to patients. She joins Cell & Gene: The Podcast's Host, Erin Harris, to discuss the near-term future of CAR-T. They also take a deep dive into the various innovati…
…
continue reading
1
The Promise of Genome Editing with Caribou Biosciences' Rachel Haurwitz, Ph.D.
23:21
23:21
Play later
Play later
Lists
Like
Liked
23:21
We love to hear from our listeners. Send us a message. On this episode of Cell & Gene: The Podcast, Rachel Haurwitz, Ph.D., CEO at Caribou Biosciences joins Host Erin Harris to discuss the evolution of genome editing, its present state, as well as its undeniable potential. They also discuss Caribou's chRDNA genome editing technology and how it diff…
…
continue reading
1
Focus Areas For Cell Therapy With Bristol Myers Squibb's Stephan Krause, Ph.D.
19:29
19:29
Play later
Play later
Lists
Like
Liked
19:29
We love to hear from our listeners. Send us a message. In June 2023, PDA held its Advanced Therapy Medicinal Products Conference in Baltimore, MD. At the conference, Stephan Krause, Ph.D., Executive Director, AS&T, CT Global Quality at Bristol Myers Squibb, sat down with Cell & Gene: The Podcast Host Erin Harris to discuss the event's major themes …
…
continue reading
1
The Intersection Of RNA, AI, And Synthetic Biology With Shape Therapeutics' Dr. Francois Vigneault
29:17
29:17
Play later
Play later
Lists
Like
Liked
29:17
We love to hear from our listeners. Send us a message. Dr. Francois Vigneault, Co-Founder, President, and CEO at Shape Therapeutics joins Cell & Gene: The Podcast's Erin Harris to discuss how RNA technologies are shaping the future of gene therapy. They also discuss AI's role in gene therapy as well as the how the CGT sector is benefiting from RNA,…
…
continue reading
1
Inside Prime Editing with Prime Medicine's Dr. Andrew Anzalone
24:34
24:34
Play later
Play later
Lists
Like
Liked
24:34
We love to hear from our listeners. Send us a message. Dr. Andrew Anzalone, Head of the Prime Editing Platform and Scientific Co-Founder of Prime Medicine joins Cell & Gene: The Podcast to talk with Host Erin Harris about prime editing - what it is and why it is a major technological advancement in gene editing. Anzalone explains why prime editing …
…
continue reading
1
Navigating CMC Challenges with Parenteral Drug Association's Glenn Wright
24:55
24:55
Play later
Play later
Lists
Like
Liked
24:55
We love to hear from our listeners. Send us a message. Glenn Wright, President and CEO of Parenteral Drug Association (PDA), sat down with Cell & Gene: The Podcast's Erin Harris at the 2023 PDA ATMP conference to discuss not only the conference's theme, “Navigating Through CMC Challenges,” but also Wright's take on CGT manufacturing strategy based …
…
continue reading
We love to hear from our listeners. Send us a message. Dr. Usman "Oz" Azam is CEO of Inspirna now but has spent much of his career in the cell and gene therapy space dedicating years as Novartis’ Global Head of Cell & Gene Therapy, President and CEO of Tmunity Therapeutics, and more. Given Oz’s tenure in cell and gene therapy space, I invited him t…
…
continue reading
1
Targeting Oncogenic Drivers for Solid Tumor Cancers with Affini-T Therapeutics' Dr. Jak Knowles
23:45
23:45
Play later
Play later
Lists
Like
Liked
23:45
We love to hear from our listeners. Send us a message. Affini-T Therapeutics combines a validated TCR discovery platform with synthetic biology switches to attack tumor biology at its root cause. Co-Founder, CEO, and President Dr. Jak Knowles joins Cell & Gene: The Podcast Host Erin Harris to discuss how the company engineers immune cells to target…
…
continue reading
1
TJU's Jefferson Institute for Bioprocessing's Impact on CGT with Parviz Shamlou
42:20
42:20
Play later
Play later
Lists
Like
Liked
42:20
We love to hear from our listeners. Send us a message. Parviz Shamlou, Vice President and Executive Director at Thomas Jefferson University joins Cell & Gene: The Podcast to talk to Host Erin Harris about Jefferson Institute for Bioprocessing (JIB), the full-service development and training organization specializing in biopharmaceuticals and biolog…
…
continue reading
1
Justin Reid // The Creative Struggle, Mental Health, & Why it's Hard to Ask for Help
28:46
28:46
Play later
Play later
Lists
Like
Liked
28:46
On this episode we chat with Justin Reid about our personal experiences with mental health, the struggle that come with that, and the importance of seeking out help.By Ryan Furr Creative
…
continue reading
1
Computational Biology's Role In Gene Therapy With Kriya Therapeutics' Dr. Shankar Ramaswamy
31:57
31:57
Play later
Play later
Lists
Like
Liked
31:57
We love to hear from our listeners. Send us a message. Shankar Ramaswamy, M.D., CEO & Co-Founder, Kriya Therapeutics joins Cell & Gene: The Podcast's Erin Harris for a discussion on the evolving role computational biology plays in gene therapy development. They also discuss the company's lessons learned from building its own North Carolina-based in…
…
continue reading
1
Devon Foster // Wedding Films, Building a Small Business, & Storm Chasing
18:54
18:54
Play later
Play later
Lists
Like
Liked
18:54
Devon Foster of Foster films talks about diving full-on into wedding video production, growing a small business, and the perils of outdoor events. Follow Devon at: http://www.dfosterfilms.comBy Ryan Furr Creative
…
continue reading
1
Ben McKinley, Founder of Cascade Web Development, on Running Your Business for the Long Term
22:10
22:10
Play later
Play later
Lists
Like
Liked
22:10
Ben McKinley is the Founder of Cascade Web Development. Cascade Web Development creates intuitive, custom software that grows with your business. Our industry-leading platforms allow you to easily manage your online presence and internal processes with high flexibility and modular functionality. Learn more at https://www.cascadewebdev.com/…
…
continue reading
1
Chris Scott // Starting a Podcast, Growing an Audience, & Finding Purpose in Content
24:33
24:33
Play later
Play later
Lists
Like
Liked
24:33
In this episode we talk with Chris Scott about his new podcast "Church with Chris," his goals for the show, and how having a deeper purpose behind content creation is a recipe for longevity in the space.By Ryan Furr Creative
…
continue reading
1
The Near-Term Future of Exosome Science with Capricor Therapeutics' Dr. Linda Marbán
28:17
28:17
Play later
Play later
Lists
Like
Liked
28:17
We love to hear from our listeners. Send us a message. Dr. Linda Marbán, Ph.D., CEO of Capricor Therapeutics, a clinical-stage biotech focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases, joins Cell & Gene: The Podcast's Erin Harris to discuss the current state and the near-term fut…
…
continue reading
1
Inside the World's First-Ever Allogeneic Approval with Atara Biotherapeutics' Pascal Touchon
40:51
40:51
Play later
Play later
Lists
Like
Liked
40:51
We love to hear from our listeners. Send us a message. In December 2022, Atara Biotherapeutics’ Ebvallo received European Commission approval as the first-ever therapy for adults and children with EBV+ PTLD. The ground-breaking approval represents the first approval of an allogeneic T-cell immunotherapy ever, globally. Atara Bio's CEO, Pascal Touch…
…
continue reading
1
Robert McClellan // Home Studio Simplified, Raw Track Reactions and Growing a Youtube Channel
40:52
40:52
Play later
Play later
Lists
Like
Liked
40:52
On this episode we've got Robert McClellan from Home Studio Simplified. We talk about home recording, online courses, growing a youtube channel, and what it's like to hear raw audio tracks from artists like Michael Jackson, The Bee Gees, and Stevie Wonder. Follow Robert at: https://www.youtube.com/c/Homestudiosimplified…
…
continue reading
1
Matt Scott, Author of The High Growth Nonprofit
28:32
28:32
Play later
Play later
Lists
Like
Liked
28:32
Matt Scott is the author The High Growth Nonprofit- proven steps to quickly double your revenue and drive impact. Matt is also the Founder of CauseMic, a consulting firm specializing in helping mission-driven organizations. Learn more at https://www.causemic.com/bookBy Dan Bruton
…
continue reading
1
The Potential of RNA Exon Editing with Ascidian Therapeutics' Romesh Subramanian, Ph.D.
20:40
20:40
Play later
Play later
Lists
Like
Liked
20:40
We love to hear from our listeners. Send us a message. Cell & Gene: The Podcast Host, Erin Harris, welcomes Romesh Subramanian, Ph.D., CEO of Ascidian Therapeutics, a Boston-based biotech focused on rewriting RNA to the pod. During the episode, Subramanian defines RNA exon editing, and they discuss the differences between RNA exon editing and gene …
…
continue reading
1
Tim Morgan, Co-Founder of DeepSurface Security
23:37
23:37
Play later
Play later
Lists
Like
Liked
23:37
In 2017, frustrated with security, policy and regulatory/compliance tools that did little to actually help reduce risk, co-founders James Dirksen and Tim Morgan set out to create a product that would provide a comprehensive picture of an organization’s threat landscape. It had to be quick, efficient and accurate, and make it easy to communicate ris…
…
continue reading
1
Jonathan Overmeyer // Golden Press Studio, entrepreneurship and Running a small business
35:01
35:01
Play later
Play later
Lists
Like
Liked
35:01
In this episode, Jonathan Overmeyer of Golden Press Studio talks about his journey in building a multi-faceted creative company, the struggles of running a small business, and working with friends.By Ryan Furr Creative
…
continue reading